Are Tanycytes the Missing Link Between Type 2 Diabetes and Alzheimer’s Disease?

[1]  H. Pattison,et al.  Type 2 diabetes in adolescents and young adults. , 2018, The lancet. Diabetes & endocrinology.

[2]  Z. Y.,et al.  Hypothalamic stem cells control ageing speed partly through exosomal miRNAs , 2018, Yearbook of Paediatric Endocrinology.

[3]  M. Migaud,et al.  A comparative study of the neural stem cell niche in the adult hypothalamus of human, mouse, rat and gray mouse lemur (Microcebus murinus) , 2018, The Journal of comparative neurology.

[4]  A. Sharif,et al.  The Versatile Tanycyte: A Hypothalamic Integrator of Reproduction and Energy Metabolism , 2018, Endocrine reviews.

[5]  V. Lioutas,et al.  Intranasal insulin in Alzheimer’s dementia or mild cognitive impairment: a systematic review , 2018, Journal of Neurology.

[6]  P. Fraser,et al.  Tau ablation in mice leads to pancreatic β cell dysfunction and glucose intolerance , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  B. Winblad,et al.  Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons , 2017, Brain : a journal of neurology.

[8]  Kristofer C. Berrett,et al.  CRISPR Epigenome Editing of AKAP150 in DRG Neurons Abolishes Degenerative IVD-Induced Neuronal Activation. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  N. Sato,et al.  Bidirectional interactions between diabetes and Alzheimer's disease , 2017, Neurochemistry International.

[10]  L. Buée,et al.  Tau deletion promotes brain insulin resistance , 2017, The Journal of experimental medicine.

[11]  Jing-Zhang Wang,et al.  The AAV-mediated and RNA-guided CRISPR/Cas9 system for gene therapy of DMD and BMD , 2017, Brain and Development.

[12]  O. Nureki,et al.  CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice , 2017, Scientific Reports.

[13]  R. Uranga,et al.  Adenovirus-mediated suppression of hypothalamic glucokinase affects feeding behavior , 2017, Scientific Reports.

[14]  P. Reddy,et al.  Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[15]  Ramesh Kandimalla,et al.  Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[16]  Yi Zhang,et al.  Single-Cell RNA-Seq Reveals Hypothalamic Cell Diversity. , 2017, Cell reports.

[17]  Min Zhang,et al.  Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease , 2017, Scientific Reports.

[18]  Vijender Chaitankar,et al.  Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice , 2017, Nature Communications.

[19]  N. Dale,et al.  A sweet taste receptor‐dependent mechanism of glucosensing in hypothalamic tanycytes , 2017, Glia.

[20]  Evan Z. Macosko,et al.  A Molecular Census of Arcuate Hypothalamus and Median Eminence Cell Types , 2017, Nature Neuroscience.

[21]  Alexandre Jourdon,et al.  Prss56, a novel marker of adult neurogenesis in the mouse brain , 2016, Brain Structure and Function.

[22]  Claudio Soto,et al.  Molecular interaction between type 2 diabetes and Alzheimer’s disease through cross-seeding of protein misfolding , 2016, Molecular Psychiatry.

[23]  D. Holtzman,et al.  Changes in insulin and insulin signaling in Alzheimer’s disease: cause or consequence? , 2016, The Journal of experimental medicine.

[24]  Patrick F. Sullivan,et al.  CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector , 2016, Molecular therapy. Nucleic acids.

[25]  I. Caillé,et al.  Hypothalamic neurogenesis persists in the aging brain and is controlled by energy-sensing IGF-I pathway , 2016, Neurobiology of Aging.

[26]  Marc Tessier-Lavigne,et al.  Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9 , 2016, Nature.

[27]  R. Bergman,et al.  Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents , 2016, Nature Medicine.

[28]  V. Balasubramaniyan,et al.  Multipotent stem cell factor UGS148 is a marker for tanycytes in the adult hypothalamus , 2015, Molecular and Cellular Neuroscience.

[29]  D. Thedens,et al.  Human iPS Cell-Derived Insulin Producing Cells Form Vascularized Organoids under the Kidney Capsules of Diabetic Mice , 2015, PloS one.

[30]  J. García-Verdugo,et al.  The LIM Homeodomain Factor Lhx2 Is Required for Hypothalamic Tanycyte Specification and Differentiation , 2014, The Journal of Neuroscience.

[31]  Feng Zhang,et al.  In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9 , 2014, Nature Biotechnology.

[32]  C. Millán,et al.  Dynamic Localization of Glucokinase and Its Regulatory Protein in Hypothalamic Tanycytes , 2014, PloS one.

[33]  Randy J. Seeley,et al.  Cooperation between brain and islet in glucose homeostasis and diabetes , 2013, Nature.

[34]  R. Bergman,et al.  FGF19 action in the brain induces insulin-independent glucose lowering. , 2013, The Journal of clinical investigation.

[35]  S. Chua,et al.  Central action of FGF19 reduces hypothalamic AGRP/NPY neuron activity and improves glucose metabolism , 2013, Molecular metabolism.

[36]  S. Bouret,et al.  Tanycyte‐like cells form a blood–cerebrospinal fluid barrier in the circumventricular organs of the mouse brain , 2013, The Journal of comparative neurology.

[37]  J. Flier,et al.  α-Tanycytes of the adult hypothalamic third ventricle include distinct populations of FGF-responsive neural progenitors , 2013, Nature Communications.

[38]  S. Bellusci,et al.  Fgf10-Expressing Tanycytes Add New Neurons to the Appetite/Energy-Balance Regulating Centers of the Postnatal and Adult Hypothalamus , 2013, The Journal of Neuroscience.

[39]  P. Carmeliet,et al.  Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting. , 2013, Cell metabolism.

[40]  N. Zavazava,et al.  PDX1-engineered embryonic stem cell-derived insulin producing cells regulate hyperglycemia in diabetic mice , 2012, Transplantation research.

[41]  D. Cai,et al.  IKKβ/NF-κB Disrupts Adult Hypothalamic Neural Stem Cells to Mediate Neurodegenerative Mechanism of Dietary Obesity and Pre-Diabetes , 2012, Nature Cell Biology.

[42]  G. Fishell,et al.  Tanycytes of the Hypothalamic Median Eminence Form a Diet-Responsive Neurogenic Niche , 2012, Nature Neuroscience.

[43]  Jean X. Jiang,et al.  Glucose increases intracellular free Ca2+ in tanycytes via ATP released through connexin 43 hemichannels , 2012, Glia.

[44]  Ruth Britton,et al.  ATP-mediated glucosensing by hypothalamic tanycytes , 2011, The Journal of physiology.

[45]  R. Raffa,et al.  Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? , 2011, British journal of clinical pharmacology.

[46]  N. Zavazava,et al.  Spontaneous In Vivo Differentiation of Embryonic Stem Cell-Derived Pancreatic Endoderm-Like Cells Corrects Hyperglycemia in Diabetic Mice , 2011, Transplantation.

[47]  Hong Qing,et al.  Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes , 2010, Neurobiology of Aging.

[48]  N. Chinookoswong,et al.  Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects. , 2009, American journal of physiology. Endocrinology and metabolism.

[49]  N. Zavazava,et al.  Insulin producing cells derived from embryonic stem cells: Are we there yet? , 2009, Journal of cellular physiology.

[50]  P. Mehta,et al.  Intranasal insulin improves cognition and modulates β-amyloid in early AD , 2008, Neurology.

[51]  N. Zavazava,et al.  Strategies for differentiating embryonic stem cells (ESC) into insulin-producing cells and development of non-invasive imaging techniques using bioluminescence , 2007, Immunologic research.

[52]  N. Tamamaki,et al.  Neurogenesis in the ependymal layer of the adult rat 3rd ventricle , 2005, Experimental Neurology.

[53]  Jan Born,et al.  Intranasal insulin improves memory in humans , 2004, Psychoneuroendocrinology.

[54]  R. Soriano,et al.  Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. , 2004, Endocrinology.

[55]  Suzanne Craft,et al.  Insulin and neurodegenerative disease: shared and specific mechanisms , 2004, The Lancet Neurology.

[56]  J. Tapia,et al.  Elevated expression of glucose transporter‐1 in hypothalamic ependymal cells not involved in the formation of the brain–cerebrospinal fluid barrier , 2001, Journal of cellular biochemistry.

[57]  H. Edlund,et al.  Attenuation of FGF signalling in mouse β-cells leads to diabetes , 2000, Nature.

[58]  G. Alonso,et al.  Tanycytes Present in the Adult Rat Mediobasal Hypothalamus Support the Regeneration of Monoaminergic Axons , 1998, Experimental Neurology.

[59]  N. Zavazava,et al.  Differentiation and lineage commitment of murine embryonic stem cells into insulin producing cells. , 2013, Methods in molecular biology.

[60]  S. Woods,et al.  Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats. , 2013, Endocrinology.

[61]  N. Zavazava,et al.  Real-time non-invasive imaging of ES cell-derived insulin producing cells. , 2009, Methods in molecular biology.

[62]  M. Reger,et al.  Intranasal insulin improves cognition and modulates beta-amyloid in early AD. , 2008, Neurology.

[63]  E. Rodríguez,et al.  Hypothalamic tanycytes: a key component of brain-endocrine interaction. , 2005, International review of cytology.

[64]  Felipe Zúñiga,et al.  Hypothalamic ependymal-glial cells express the glucose transporter GLUT2, a protein involved in glucose sensing. , 2003, Journal of neurochemistry.

[65]  H. Edlund,et al.  Attenuation of FGF signalling in mouse beta-cells leads to diabetes. , 2000, Nature.